These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23530883)

  • 1. Analytical performance validation of a coronary heart disease risk assessment multi-analyte proteomic test.
    Nolan N; Tee L; Vijayakumar S; Burazor I; Hytopoulos E; Biggs WH; Beggs M; French C; Harrington DS
    Expert Opin Med Diagn; 2013 Mar; 7(2):127-36. PubMed ID: 23530883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis.
    Eastman PS; Manning WC; Qureshi F; Haney D; Cavet G; Alexander C; Hesterberg LK
    J Pharm Biomed Anal; 2012 Nov; 70():415-24. PubMed ID: 22749821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts.
    Cross DS; McCarty CA; Hytopoulos E; Beggs M; Nolan N; Harrington DS; Hastie T; Tibshirani R; Tracy RP; Psaty BM; McClelland R; Tsao PS; Quertermous T
    Curr Med Res Opin; 2012 Nov; 28(11):1819-30. PubMed ID: 23092312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of a novel coronary heart disease risk-assessment test to further classify intermediate-risk patients.
    Solomon MD; Tirupsur A; Hytopoulos E; Beggs M; Harrington DS; French C; Quertermous T
    Clin Cardiol; 2013 Oct; 36(10):621-7. PubMed ID: 23929798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
    Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
    J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality specifications and the assessment of the biochemical risk of atherosclerosis.
    Rifai N; Warnick GR
    Clin Chim Acta; 2004 Aug; 346(1):55-64. PubMed ID: 15234636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
    Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
    Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia.
    Blankley RT; Gaskell SJ; Whetton AD; Dive C; Baker PN; Myers JE
    BJOG; 2009 Oct; 116(11):1473-80. PubMed ID: 19663911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease.
    Eda S; Kaufmann J; Molwitz M; Vorberg E
    Scand J Clin Lab Invest Suppl; 1999; 230():32-5. PubMed ID: 10389199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical validation of a multi-biomarker algorithmic test for prediction of progressive kidney function decline in patients with early-stage kidney disease.
    Connolly P; Stapleton S; Mosoyan G; Fligelman I; Tonar YC; Fleming F; Donovan MJ
    Clin Proteomics; 2021 Nov; 18(1):26. PubMed ID: 34789168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical validation of a novel multi-analyte plasma test for lung nodule characterization.
    Trivedi NN; Brown JK; Rubenstein T; Rostykus AD; Fish AL; Yu H; Carbonell L; Juang A; Kamer S; Patel B; Sidhu M; Vuong D; Wang S; Beggs M; Wu AH; Arjomandi M
    Biomed Res Rev; 2018 Dec; 2(3):. PubMed ID: 32923944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample to sample carryover: a source of analytical laboratory error and its relevance to integrated clinical chemistry/immunoassay systems.
    Armbruster DA; Alexander DB
    Clin Chim Acta; 2006 Nov; 373(1-2):37-43. PubMed ID: 16777083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter assessment of the analytical performance of the routine thyroid panel on the Olympus AU3000i immunoassay system.
    Bertsch T; Aschenneller C; Herzog V; Dupuy AM; Bargnoux AS; Badiou S; Ebel A; Winter A; Graf A; Rauch S; Durner J; Holdenrieder S; Fraunberger P; Gamble R; Sheridan B; Kukula J; Kenny P; Cristol JP
    Clin Lab; 2009; 55(11-12):447-58. PubMed ID: 20225667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of persons at high risk of coronary heart disease--a mathematical formula based on biochemical, anthropometric and clinical markers.
    Mukherjee M; Dastur DK; Soneji SL
    J Assoc Physicians India; 1996 Jan; 44(1):12-8. PubMed ID: 8773086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
    Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
    Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistency of a two clinical site sample collection: a proteomics study.
    Wiesner C; Hannum C; Reckamp K; Figlin R; Dubridge R; Roy SM; Lin S; Becker CH; Jones T; Hiller J; Cheville JC; Wilson K
    Proteomics Clin Appl; 2010 Sep; 4(8-9):726-38. PubMed ID: 21137090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variation.
    Jackson DH; Banks RE
    Proteomics Clin Appl; 2010 Mar; 4(3):250-70. PubMed ID: 21137047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How alternative are immunoassay systems employing non-radioisotopic labels? A comparative appraisal of their main analytical characteristics.
    Pelizzola D; Bombardieri E; Brocchi A; Cappelli G; Coli A; Federghini M; Giganti M; Gion M; Madeddu G; Maussieri ML
    Q J Nucl Med; 1995 Dec; 39(4):251-63. PubMed ID: 8624786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
    Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.